Camera traps are widely used in wildlife research and monitoring, so it is imperative to understand their strengths, limitations, and potential for increasing impact. We investigated a decade of use of wildlife cameras (2012–2022) with a case study on Australian terrestrial vertebrates using a multifaceted approach. We (i) synthesised information from a literature review; (ii) conducted an online questionnaire of 132 professionals; (iii) hosted an in‐person workshop of 28 leading experts representing academia, non‐governmental organisations (NGOs), and government; and (iv) mapped camera trap usage based on all sources. We predicted that the last decade would have shown: (i) exponentially increasing sampling effort, a continuation of camera usage trends up to 2012; (ii) analytics to have shifted from naive presence/absence and capture rates towards hierarchical modelling that accounts for imperfect detection, thereby improving the quality of outputs and inferences on occupancy, abundance, and density; and (iii) broader research scales in terms of multi‐species, multi‐site and multi‐year studies. However, the results showed that the sampling effort has reached a plateau, with publication rates increasing only modestly. Users reported reaching a saturation point in terms of images that could be processed by humans and time for complex analyses and academic writing. There were strong taxonomic and geographic biases towards medium–large mammals (>500 g) in forests along Australia's southeastern coastlines, reflecting proximity to major cities. Regarding analytical choices, bias‐prone indices still accounted for ~50% of outputs and this was consistent across user groups. Multi‐species, multi‐site and multiple‐year studies were rare, largely driven by hesitancy around collaboration and data sharing. There is no widely used repository for wildlife camera images and the Atlas of Living Australia (ALA) is the dominant repository for sharing tabular occurrence records. However, the ALA is presence‐only and thus is unsuitable for creating detection histories with absences, inhibiting hierarchical modelling. Workshop discussions identified a pressing need for collaboration to enhance the efficiency, quality and scale of research and management outcomes, leading to the proposal of a Wildlife Observatory of Australia (WildObs). To encourage data standards and sharing, WildObs should (i) promote a metadata collection app; (ii) create a tagged image repository to facilitate artificial intelligence/machine learning (AI/ML) computer vision research in this space; (iii) address the image identification bottleneck via the use of AI/ML‐powered image‐processing platforms; (iv) create data commons for detection histories that are suitable for hierarchical modelling; and (v) provide capacity building and tools for hierarchical modelling. Our review highlights that while Australia's investments in monitoring biodiversity with cameras position it to be a global leader in this context, realising that potential requires a paradigm shift towards best practices for collecting, curating, sharing and analysing ‘Big Data’. Our findings and framework have broad applicability outside Australia to enhance camera usage to meet conservation and management objectives ranging from local to global scales. This review articulates a country/continental observatory approach that is also suitable for international collaborative wildlife research networks.

The toxin composition of snake venoms and, thus, their functional activity, can vary between and within species. Intraspecific venom variation across a species’ geographic range is a major concern for antivenom treatment of envenomations, particularly for countries like French Guiana that lack a locally produced antivenom. Bothrops asper and Bothrops atrox are the most medically significant species of snakes in Latin America, both producing a variety of clinical manifestations, including systemic bleeding. These pathophysiological actions are due to the activation by the venom of the blood clotting factors Factor X and prothrombin, thereby causing severe consumptive coagulopathy. Both species are extremely wide-ranging, and previous studies have shown their venoms to exhibit regional venom variation. In this study, we investigate the differential coagulotoxic effects on human plasma of six venoms (four B. asper and two B. atrox samples) from different geographic locations, spanning from Mexico to Peru. We assessed how the venom variation of these venom samples affects neutralisation by five regionally available antivenoms: Antivipmyn, Antivipmyn-Tri, PoliVal-ICP, Bothrofav, and Soro Antibotrópico (SAB). The results revealed both inter- and intraspecific variations in the clotting activity of the venoms. These variations in turn resulted in significant variation in antivenom efficacy against the coagulotoxic effects of these venoms. Due to variations in the venoms used in the antivenom production process, antivenoms differed in their species-specific or geographical neutralisation capacity. Some antivenoms (PoliVal-ICP, Bothrofav, and SAB) showed species-specific patterns of neutralisation, while another antivenom (Antivipmyn) showed geographic-specific patterns of neutralisation. This study adds to current knowledge of Bothrops venoms and also illustrates the importance of considering evolutionary biology when developing antivenoms. Therefore, these results have tangible, real-world implications by aiding evidence-based design of antivenoms for treatment of the envenomed patient. We stress that these in vitro studies must be backed by future in vivo studies and clinical trials before therapeutic guidelines are issued regarding specific antivenom use in a clinical setting.

Despite coagulotoxicity being a primary weapon for prey capture by Bothrops species (lancehead pit vipers) and coagulopathy being a major lethal clinical effect, a genus-wide comparison has not been undertaken. To fill this knowledge gap, we used thromboelastography to compare 37 venoms, from across the full range of geography, taxonomy, and ecology, for their action upon whole plasma and isolated fibrinogen. Potent procoagulant toxicity was shown to be the main venom effect of most of the species tested. However, the most basal species (B. pictus) was strongly anticoagulant; this is consistent with procoagulant toxicity being a novel trait that evolved within Bothrops subsequent to their split from anticoagulant American pit vipers. Intriguingly, two of the arboreal species studied (B. bilineatus and B. taeniatus) lacked procoagulant venom, suggesting differential evolutionary selection pressures. Notably, some terrestrial species have secondarily lost the procoagulant venom trait: the Mogi Mirim, Brazil locality of B. alternatus; San Andres, Mexico locality of B. asper; B. diporus; and the São Roque of B. jararaca. Direct action on fibrinogen was extremely variable; this is consistent with previous hypotheses regarding it being evolutionary decoupled due to procoagulant toxicity being the primary prey-capture weapon. However, human patients live long enough for fibrinogen depletion to be clinically significant. The extreme variability may be reflective of antivenom variability, with these results thereby providing a foundation for such future work of clinical relevance. Similarly, the venom diversification trends relative to ecological niche will also be useful for integration with natural history data, to reconstruct the evolutionary pressures shaping the venoms of these fascinating snakes.

Snakebite is a globally neglected tropical disease, with coagulation disturbances being the primary pathology of many deadly snake venoms. Age-related differences in human plasma have been abundantly reported, yet the effect that these differences pose regarding snakebite is largely unknown. We tested for differences in coagulotoxic effects (via clotting time) of multiple snake venoms upon healthy human adult (18+) and paediatric (median 3.3 years old) plasma in vivo and compared these effects to the time it takes the plasmas to clot without the addition of venom (the spontaneous clotting time). We tested venoms from 15 medically significant snake species (from 13 genera) from around the world with various mechanisms of coagulotoxic actions, across the three broad categories of procoagulant, pseudo-procoagulant, and anticoagulant, to identify any differences between the two plasmas in their relative pathophysiological vulnerability to snakebite. One procoagulant venom (Daboia russelii, Russell’s Viper) produced significantly greater potency on paediatric plasma compared with adult plasma. In contrast, the two anticoagulant venoms (Pseudechis australis, Mulga Snake; and Bitis cornuta, Many-horned Adder) were significantly more potent on adult plasma. All other procoagulant venoms and all pseudo-procoagulant venoms displayed similar potency across both plasmas. Our preliminary results may inform future studies on the effect of snake venoms upon plasmas from different age demographics and hope to reduce the burden of snakebite upon society.